Patents by Inventor Alexander Riechers

Alexander Riechers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Non-hydrophobic compounds for use in treating metastasis and/or cartilage defect
    Patent number: 10828281
    Abstract: The present invention is directed to compounds, tautomers, stereoisomers, and chemically modified compounds thereof, and their use in preventing and/or treating tumors of metastasis and/or cartilage defect, and to a pharmaceutical composition comprising such compound.
    Type: Grant
    Filed: May 24, 2016
    Date of Patent: November 10, 2020
    Assignee: Friedrich-Alexander-Universität Erlangen-Nürnberg
    Inventors: Anja-Katrin Bosserhoff, Alexander Riechers, Burkhard König, Manuel Bause, Fabian Rauscher
  • NON-HYDROPHOBIC COMPOUNDS FOR USE IN TREATING METASTASIS AND/OR CARTILAGE DEFECT
    Publication number: 20180280356
    Abstract: The present invention is directed to compounds, tautomers, stereoisomers, and chemically modified compounds thereof, and their use in preventing and/or treating tumors of metastasis and/or cartilage defect, and to a pharmaceutical composition comprising such compound.
    Type: Application
    Filed: May 24, 2016
    Publication date: October 4, 2018
    Inventors: Anja-Katrin Bosserhoff, Alexander Riechers, Burkhard König, Manuel Bause, Fabian Rauscher
  • Peptides or Antibodies Which Bind to Melanoma Inhibitory Activity (MIA) Protein
    Publication number: 20130095122
    Abstract: The present invention relates to peptides and antibodies which bind to melanoma inhibitory activity protein and the uses of such peptides and antibodies. The invention also relates to nucleic acids coding for such peptides or antibodies. The invention also relates to pharmaceutical compositions comprising such peptides or antibodies or such nucleic acids. The present invention also relates to small molecule compounds which bind to melanoma inhibitory activity protein and to uses of such small molecule compounds. Moreover, the present invention also relates to a method of preventing dimerization and/or aggregation of melanoma inhibitory activity (MIA) protein. The invention is based on the identification of the relevant sites of interaction of the MIA protein with the inhibitory peptides/antibodies.
    Type: Application
    Filed: March 17, 2011
    Publication date: April 18, 2013
    Inventors: Anja Katrin Bosserhoff, Burkhard König, Alexander Riechers, Jennifer Schmidt